prednisolone has been researched along with Congestive Ophthalmopathy in 22 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this observational study, we intended to examine whether the use of high doses of radioiodine (RAI) [22 mCi (814 MBq)] with prophylaxis of oral glucocorticoids (oGCS) does not exacerbate Graves ophthalmopathy (GO) in smokers and non-smokers, especially regards to the urine level cotinine and ocular changes before and after RIT." | 7.79 | The influence of radioiodine therapy on ocular changes and their relation to urine cotinine level in patients with Graves' Ophthalmopathy. ( Budny, B; Czarnywojtek, A; Florek, E; Komar-Rychlicka, K; Kurdybacha, P; Miechowicz, I; Ruchala, M; Szczepanek, E; Waligorska-Stachura, J; Wasko, R; Zgorzalewicz-Stachowiak, M, 2013) |
| "A 55-year-old woman with concurrent active thyroid orbitopathy and B-cell lymphoma developed acute exacerbation of thyroid orbitopathy after receiving Rituximab, cyclophosphamide, hydroxydaunorubicin, Prednisone (R-CHOP) chemotherapy, presenting with subtotal loss of vision and severe eyelid edema." | 3.88 | Chemotherapy-induced exacerbations of thyroid orbitopathy in a patient with B-cell lymphoma. ( Croon-de Boer, F; Dalm, VASH; Liu, C; Paridaens, D; van Hagen, PM, 2018) |
| " In this observational study, we intended to examine whether the use of high doses of radioiodine (RAI) [22 mCi (814 MBq)] with prophylaxis of oral glucocorticoids (oGCS) does not exacerbate Graves ophthalmopathy (GO) in smokers and non-smokers, especially regards to the urine level cotinine and ocular changes before and after RIT." | 3.79 | The influence of radioiodine therapy on ocular changes and their relation to urine cotinine level in patients with Graves' Ophthalmopathy. ( Budny, B; Czarnywojtek, A; Florek, E; Komar-Rychlicka, K; Kurdybacha, P; Miechowicz, I; Ruchala, M; Szczepanek, E; Waligorska-Stachura, J; Wasko, R; Zgorzalewicz-Stachowiak, M, 2013) |
| "To measure the 8-hydroxy-2'-deoxyguanosine (8-OHdG) level in patients having active Graves ophthalmopathy (GO) and to compare this oxidative stress biomarker and the clinical evolution of patients after systemic corticosteroid treatment." | 3.74 | Oxidative stress change by systemic corticosteroid treatment among patients having active graves ophthalmopathy. ( Cheng, CY; Hsu, WM; Kao, SC; Kau, HC; Lee, CF; Tsai, CC; Wei, YH, 2007) |
| " We concluded that orbital MR imaging combined with CAS could improve the sensitivity of detection of active disease and the prediction of the response to ivGC." | 2.75 | Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves' ophthalmopathy. ( Murakami, T; Nakashima, A; Noguchi, H; Noguchi, S; Noguchi, Y; Ohyabu, Y; Tachibana, S, 2010) |
| "Gaze-evoked amaurosis (GEA) describes visual loss associated with eccentric gaze that recovers when the eye is returned to primary position." | 2.52 | Dysthyroid Orbitopathy Presenting with Gaze-Evoked Amaurosis: Case Report and Review of the Literature. ( Bremner, FD; Orlans, HO, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 10 (45.45) | 24.3611 |
| 2020's | 4 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Uzlu, D | 1 |
| Bulanık, FT | 1 |
| Erdöl, H | 1 |
| Günay, M | 1 |
| Bulanık, ÖB | 1 |
| Perepelova, MA | 1 |
| Zaitseva, EL | 1 |
| Bessmertnaya, EG | 1 |
| Grusha, YO | 1 |
| Sviridenko, NY | 1 |
| Galstyan, GR | 1 |
| Balakrishnan, N | 1 |
| Meel, R | 1 |
| Das, D | 1 |
| Detiger, SE | 1 |
| Kremer, TM | 1 |
| A S H Dalm, V | 1 |
| de Keizer, ROB | 1 |
| Wubbels, RJ | 1 |
| Metselaar, JM | 1 |
| van Hagen, PM | 2 |
| Peeters, RP | 1 |
| Paridaens, D | 2 |
| Liu, C | 1 |
| Dalm, VASH | 1 |
| Croon-de Boer, F | 1 |
| Czarnywojtek, A | 1 |
| Zgorzalewicz-Stachowiak, M | 1 |
| Budny, B | 1 |
| Wasko, R | 1 |
| Florek, E | 1 |
| Szczepanek, E | 1 |
| Komar-Rychlicka, K | 1 |
| Waligorska-Stachura, J | 1 |
| Kurdybacha, P | 1 |
| Miechowicz, I | 1 |
| Ruchala, M | 1 |
| Higashiyama, T | 1 |
| Nishida, Y | 1 |
| Morino, K | 1 |
| Ugi, S | 1 |
| Nishio, Y | 1 |
| Maegawa, H | 1 |
| Ohji, M | 1 |
| Watanabe, N | 1 |
| Noh, JY | 1 |
| Kozaki, A | 1 |
| Iwaku, K | 1 |
| Sekiya, K | 1 |
| Kosuga, Y | 1 |
| Matsumoto, M | 1 |
| Suzuki, M | 1 |
| Yoshihara, A | 1 |
| Ohye, H | 2 |
| Kobayashi, S | 1 |
| Kunii, Y | 1 |
| Mukasa, K | 1 |
| Sugino, K | 1 |
| Inoue, T | 1 |
| Ito, K | 1 |
| Sendhil Kumaran, M | 1 |
| Dutta, P | 1 |
| Sakia, U | 1 |
| Dogra, S | 1 |
| Orlans, HO | 1 |
| Bremner, FD | 1 |
| Lazarus, JH | 1 |
| Bartalena, L | 1 |
| Marcocci, C | 1 |
| Kahaly, GJ | 1 |
| Krassas, G | 1 |
| Wiersinga, WM | 1 |
| Alkawas, AA | 1 |
| Hussein, AM | 1 |
| Shahien, EA | 1 |
| Tachibana, S | 1 |
| Murakami, T | 1 |
| Noguchi, H | 1 |
| Noguchi, Y | 1 |
| Nakashima, A | 1 |
| Ohyabu, Y | 1 |
| Noguchi, S | 1 |
| Rajendram, R | 1 |
| Bunce, C | 1 |
| Lee, RW | 1 |
| Morley, AM | 1 |
| Tsai, CC | 2 |
| Kau, HC | 2 |
| Tsai, HH | 1 |
| Kao, SC | 2 |
| Hsu, WM | 2 |
| Ng, CM | 1 |
| Yuen, HK | 1 |
| Choi, KL | 1 |
| Chan, MK | 1 |
| Yuen, KT | 1 |
| Ng, YW | 1 |
| Tiu, SC | 1 |
| Kubota, S | 1 |
| Nishihara, E | 1 |
| Kudo, T | 1 |
| Ito, M | 1 |
| Fukata, S | 1 |
| Amino, N | 1 |
| Kuma, K | 1 |
| Miyauchi, A | 1 |
| Salvatore, D | 1 |
| Fenzi, G | 1 |
| Meyer, PA | 1 |
| Hiromatsu, Y | 1 |
| Cheng, CY | 1 |
| Lee, CF | 1 |
| Wei, YH | 1 |
| Acharya, SH | 1 |
| Avenell, A | 1 |
| Philip, S | 1 |
| Burr, J | 1 |
| Bevan, JS | 1 |
| Abraham, P | 1 |
5 reviews available for prednisolone and Congestive Ophthalmopathy
| Article | Year |
|---|---|
Dysthyroid Orbitopathy Presenting with Gaze-Evoked Amaurosis: Case Report and Review of the Literature.
Topics: Administration, Oral; Blindness; Fixation, Ocular; Glucocorticoids; Graves Ophthalmopathy; Humans; M | 2015 |
Orbital radiotherapy for adult thyroid eye disease.
Topics: Adult; Anti-Inflammatory Agents; Female; Graves Ophthalmopathy; Humans; Male; Methylprednisolone; Pr | 2012 |
Avoiding surgery for thyroid eye disease.
Topics: Adult; Aged; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graves Ophthalmopat | 2006 |
[Steroid therapy for Graves' ophthalmopathy].
Topics: Administration, Oral; Combined Modality Therapy; Drug Administration Schedule; Graves Ophthalmopathy | 2006 |
Radioiodine therapy (RAI) for Graves' disease (GD) and the effect on ophthalmopathy: a systematic review.
Topics: Antithyroid Agents; Graves Disease; Graves Ophthalmopathy; Humans; Iodine Radioisotopes; Prednisolon | 2008 |
7 trials available for prednisolone and Congestive Ophthalmopathy
| Article | Year |
|---|---|
Radioiodine-Associated Exacerbation of Graves' Orbitopathy in the Japanese Population: Randomized Prospective Study.
Topics: Adult; Aged; Chemoprevention; Disease Progression; Female; Graves Disease; Graves Ophthalmopathy; Hu | 2015 |
Orbital steroid injection versus oral steroid therapy in management of thyroid-related ophthalmopathy.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Exophthalmos; Eye Movements; Female; Glucocor | 2010 |
Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves' ophthalmopathy.
Topics: Diagnostic Techniques, Ophthalmological; Drug Therapy, Combination; Early Diagnosis; Female; Glucoco | 2010 |
Pulsatile ocular blood flow change after treatment with systemic steroid in patients with Graves' ophthalmopathy.
Topics: Administration, Oral; Adult; Aged; Eye; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Inje | 2006 |
Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves' ophthalmopathy: a preliminary study.
Topics: Administration, Oral; Analysis of Variance; Chi-Square Distribution; Combined Modality Therapy; Doub | 2005 |
Effect of high dose methylprednisolone pulse therapy followed by oral prednisolone administration on the production of anti-TSH receptor antibodies and clinical outcome in Graves' disease.
Topics: Administration, Oral; Adult; Autoantibodies; Case-Control Studies; Female; Graves Disease; Graves Op | 2005 |
Avoiding surgery for thyroid eye disease.
Topics: Adult; Aged; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graves Ophthalmopat | 2006 |
11 other studies available for prednisolone and Congestive Ophthalmopathy
| Article | Year |
|---|---|
An evaluation of corneal endothelial cell morphology in patients with thyroid-associated ophthalmopathy.
Topics: Cell Count; Endothelial Cells; Endothelium, Corneal; Female; Graves Ophthalmopathy; Humans; Male; Pr | 2023 |
[An integrated approach to the treatment of pretibial myxedema based on pulse therapy with prednisolone and electrical neuromyostimulation (FREMS-therapy) in a patient with Graves' disease and thyroid eye disease].
Topics: Graves Disease; Graves Ophthalmopathy; Humans; Myxedema; Patients; Prednisolone | 2023 |
Case of IgG4 orbitopathy's remarkable response to oral corticosteroid therapy.
Topics: Administration, Oral; Adrenal Cortex Hormones; Diagnosis, Differential; Graves Ophthalmopathy; Human | 2020 |
A pilot study on the use of prednisolone-encapsulated liposomes for the treatment of moderate-to-severe Graves' orbitopathy with reduced systemic steroid exposure.
Topics: Adult; Aged; Drug Implants; Female; Follow-Up Studies; Glucocorticoids; Graves Ophthalmopathy; Human | 2021 |
Chemotherapy-induced exacerbations of thyroid orbitopathy in a patient with B-cell lymphoma.
Topics: Administration, Oral; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy P | 2018 |
The influence of radioiodine therapy on ocular changes and their relation to urine cotinine level in patients with Graves' Ophthalmopathy.
Topics: Adult; Chemoradiotherapy; Cotinine; Dose-Response Relationship, Radiation; Female; Glucocorticoids; | 2013 |
Use of MRI signal intensity of extraocular muscles to evaluate methylprednisolone pulse therapy in thyroid-associated ophthalmopathy.
Topics: Administration, Oral; Adult; Aged; Diplopia; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; | 2015 |
Long-term follow-up and epidemiological trends in patients with pretibial myxedema: an 11-year study from a tertiary care center in northern India.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Clobetasol; Drug Therapy, Combination; | 2015 |
Glucocorticoid administration for Graves' hyperthyroidism treated by radioiodine. A questionnaire survey among members of the European Thyroid Association.
Topics: Glucocorticoids; Graves Disease; Graves Ophthalmopathy; Humans; Hyperthyroidism; Iodine Radioisotope | 2010 |
Do glucocorticoids affect outcome in Graves' disease following radioiodine therapy?
Topics: Adult; Glucocorticoids; Graves Disease; Graves Ophthalmopathy; Humans; Iodine Radioisotopes; Middle | 2006 |
Oxidative stress change by systemic corticosteroid treatment among patients having active graves ophthalmopathy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Administration, Oral; Adult; Biomarkers; Deoxyguanosine; Enzyme-Linked | 2007 |